Established immune markers even now protect their relevance for scientific selection-earning in breast cancer cure with even extended meanings. Estrogen receptor (ER) stage shouldn't only be classified in good or detrimental. Small ER concentrations ?10% of labeled cells must be managed differently (LoE 1a/A/In the past++). Tumors with small ER sta